Fig. 4
Pneumonia outcome. Data from 12 trials (n = 1471 patients) were included, analyzed using the random effects model. The risk of pneumonia was similar in both groups. PPI proton pump inhibitor, H2RA histamine-2-receptor antagonist. IV Inverse Variance